Search Results - "Heftdal, Line D."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
  2. 2

    The IL-20 Cytokine Family in Rheumatoid Arthritis and Spondyloarthritis by Kragstrup, Tue W, Andersen, Thomas, Heftdal, Line D, Hvid, Malene, Gerwien, Jens, Sivakumar, Pallavur, Taylor, Peter C, Senolt, Ladislav, Deleuran, Bent

    Published in Frontiers in immunology (25-09-2018)
    “…This review describes the IL-20 family of cytokines in rheumatoid arthritis (RA) and spondyloartrhitits (SpA) including psoriatic arthritis. The IL-20 receptor…”
    Get full text
    Journal Article
  3. 3

    IL-12/IL-23p40 identified as a downstream target of apremilast in ex vivo models of arthritis by Kragstrup, Tue W., Adams, Mary, Lomholt, Søren, Nielsen, Morten A., Heftdal, Line D., Schafer, Peter, Deleuran, Bent

    “…Background: Apremilast (Otezla®) is a phosphodiesterase 4 (PDE4) inhibitor approved for the treatment of psoriasis and psoriatic arthritis (PsA), but the…”
    Get full text
    Journal Article
  4. 4

    Abstract 126: MYC-driven lymphomas suppress NK surveillance by blocking maturation of early NK cells by Heftdal, Line D., Swaminathan, Srividya, Felsher, Dean W.

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…The MYC oncogene is commonly overexpressed in hematopoietic cancers. In a transgenic mouse model of MYC-induced T-cell lymphoma, we found that there was a…”
    Get full text
    Journal Article
  5. 5

    IL-12/IL-23p40 identified as a downstream target of apremilast in models of arthritis by Tue W. Kragstrup, Mary Adams, Søren Lomholt, Morten A. Nielsen, Line D. Heftdal, Peter Schafer, Bent Deleuran

    “…Background: Apremilast (Otezla ® ) is a phosphodiesterase 4 (PDE4) inhibitor approved for the treatment of psoriasis and psoriatic arthritis (PsA), but the…”
    Get full text
    Journal Article